Home \ Neurology \ Management of elderly patients with chronic cerebral ischemia

Features of conducting elderly patients with chronic brain ischemia

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:
  • 01:30

    The main problems of cognitive disorders in the elderly and dementia.

  • 05:04

    Scales and identification of the degree of cognitive deficiency

  • 07:14

    Screening scales: Mini Cog, a brief scale for assessing mental status, Montreal scale for assessing cognitive functions

  • 10:00

    General examination of the patient and the importance of turning on tests in the examination

  • 12:35

    Pharmacotherapy of elderly patients on the basis of clinical recommendations

  • 14:40

    Criteria for choosing the drug and exclusion of polypragmasis.

  • 15:25

    Mexidol® in old age - an effective and safe drug

  • 18:02

    The study of the drug Mexidol® on elderly patients. Subanaliz.

  • 20:19

    Complex management of a patient with cognitive disorders

  • 21:03

    A resource for cognitive training for patients: https://memo.expert/

Evgeniya Viktorovna Yekusheva – Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation of the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia

Mkhitaryan Elen Araikovna – PhD, Associate Professor of the Department of Aging Diseases of the Faculty of Continuing Professional Education of the Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, Head of the Laboratory of Neurogeriatrics of the Russian Scientific Clinical Center

Announcement:

Age is a relative concept. In the last century, 60 years was considered old age. Nowadays, patients in their 70s and even 80s are often seen at the doctor's office. Cognitive impairments can be a sign of serious illnesses and require medical attention. Diagnosis of cognitive impairment should begin early. Mexidol® is an effective and safe medication for the elderly . The video presents diagnostic methods and explains the principles of treatment for cognitive impairment in patients. 

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:
  • 01:30

    The main problems of cognitive disorders in the elderly and dementia.

  • 05:04

    Scales and identification of the degree of cognitive deficiency

  • 07:14

    Screening scales: Mini Cog, a brief scale for assessing mental status, Montreal scale for assessing cognitive functions

  • 10:00

    General examination of the patient and the importance of turning on tests in the examination

  • 12:35

    Pharmacotherapy of elderly patients on the basis of clinical recommendations

  • 14:40

    Criteria for choosing the drug and exclusion of polypragmasis.

  • 15:25

    Mexidol® in old age - an effective and safe drug

  • 18:02

    The study of the drug Mexidol® on elderly patients. Subanaliz.

  • 20:19

    Complex management of a patient with cognitive disorders

  • 21:03

    A resource for cognitive training for patients: https://memo.expert/

Block of articles on this topic

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

Registered on ClinicalTrials 

A.I. FEDIN1, V.V. ZAKHAROV2, M.M. TANASHYAN3, E.I. CHUKANOVA1, E.N. MAJIDOVA4, L.A. SCHEPANKEVICH5.6, O.D. OSTROUMOVA7

1Pirogov Russian National Research Medical University, Moscow, Russia;
2I.M. Sechenov First Moscow Medical University,
3Neurology Research Center,
4, Russia;
5Novosibirsk State Medical University, Novosibirsk
6Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia;
7Russian Medical Academy of Continuous Professional Education, Moscow, Russia

 

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2021, Vol. 121, No. 11

Read more
The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. ZAKHAROV1, O.N. TKACHEV2,3, E.A. MKHITARYAN2,3, A.I. FEDIN2

Read more
Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. ZAKHAROV1, A.I. FEDIN2, E.A. MKHITARYAN2,3

Read more
Personal: Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

Authors:
L.N. ELISEEV, S.V. KARTASHOVA

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

Read more
Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. BOGOLEPOVA1,2

1N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia;
2Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Read more

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com